Spironolactone improves nitric oxide/cGMP pathway in L-name-induced hypertension.

被引:0
|
作者
Pechanova, Olga
Matuskova, Jana
Paulis, Luclovit
Simko, Fedor
机构
[1] Slovak Acad Sci, Inst Normal & Patholog Physiol, Bratislava, Slovakia
[2] Comenius Univ, Fac Med, Dept Pathophysiol, Bratislava, Slovakia
[3] CRC, AS CR, Inst Physiol, Prague, Czech Republic
关键词
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:346 / 346
页数:1
相关论文
共 50 条
  • [1] Spironolactone improves nitric oxide/cGMP pathway in L-NAME-induced hypertension
    Pechanova, O.
    Matuskova, J.
    Paulis, L.
    Jendekova, L.
    Kojsova, S.
    Simko, F.
    HYPERTENSION, 2006, 48 (04) : 773 - 773
  • [2] Spironolactone prevents L-NAME-induced hypertension by improving nitric oxide/cGMP pathway
    Pechanova, O.
    Matuskova, J.
    Jendekova, L.
    Kojsova, S.
    Paulis, L.
    Simko, F.
    JOURNAL OF HYPERTENSION, 2006, 24 : S100 - S100
  • [3] The effect of captopril and spironolactone on renal metabolism in L-NAME-induced hypertension
    Pechanova, O
    Capiková, D
    Lupták, I
    Matusková, J
    Simko, F
    JOURNAL OF HYPERTENSION, 2004, 22 : S41 - S41
  • [4] Genetic control of renal damage in rats with L-NAME-induced hypertension.
    VanDokkum, RPE
    Jacob, HJ
    Provoost, AP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A3100 - A3100
  • [5] Genetic control of susceptibility to glomerular damage in rats with L-NAME-induced hypertension.
    VanDookum, RPE
    Jacob, JH
    Provoost, AP
    KIDNEY INTERNATIONAL, 1997, 52 (02) : 566 - 566
  • [6] The contribution of nitric oxide to renal vascular wall thickening in rats with l-NAME-induced hypertension
    T. Yoneyama
    Sakae Ohkawa
    Tomoko Watanabe
    Mari Odamaki
    Hiromichi Kumagai
    Masato Kimura
    Akira Hishida
    Virchows Archiv, 1998, 433 : 549 - 557
  • [7] The contribution of nitric oxide to renal vascular wall thickening in rats with L-NAME-induced hypertension
    Yoneyama, T
    Ohkawa, S
    Watanabe, T
    Odamaki, M
    Kumagai, H
    Kimura, M
    Hishida, A
    VIRCHOWS ARCHIV, 1998, 433 (06) : 549 - 557
  • [8] Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-Induced hypertension
    Simko, F.
    Matuskova, J.
    Luptak, I.
    Pincikova, T.
    Krajcirovicova, K.
    Stvrtina, S.
    Pomsar, J.
    Pelouch, V.
    Paulis, L.
    Pechanova, O.
    PHYSIOLOGICAL RESEARCH, 2007, 56 : S25 - S32
  • [9] Spironolactone differently influences remodeling of the left ventricle and aorta in L-NAME-induced hypertension
    Simko, F.
    Matuskova, J.
    Luptak, I.
    Pineikova, T.
    Krajcirovicova, K.
    Stvrtina, S.
    Pomsar, J.
    Pelouch, V.
    Paulis, L.
    Pechanova, O.
    JOURNAL OF HYPERTENSION, 2008, 26 : S443 - S443
  • [10] Regression of L-NAME-induced hypertension: The role of nitric oxide and endothelium-derived constricting factor
    Paulis, Ludovit
    Zicha, Josef
    Kunes, Jaroslav
    Hojna, Silvie
    Behuliak, Michal
    Celec, Peter
    Kojsova, Stanislava
    Pechanova, Olga
    Simko, Fedor
    HYPERTENSION RESEARCH, 2008, 31 (04) : 793 - 803